Cardialysis, Sticares InterACT collaborate on cardio services

By Nick Taylor

- Last updated on GMT

Related tags Contract research organization

Advanced cardiovascular and metabolic services will be provided to biopharm by a strategic collaboration between CROs Cardialysis and Sticares InterACT.

Partnering expands the breadth and depth of services offered by The Netherlands-based contract research organisations (CRO). Both CROs have expertise in cardiology, are geographically close and have similar backgrounds which give academic links and access to new technologies.

Using these links to academia the companies can provide more advanced cardiovascular trial services than other CROs, Mark Neijssel, team leader account management and marketing services at Cardialysis, told Outsourcing-Pharma.

For instance, through its academic links Cardialysis accesses novel imaging modalities at an early stage of their development. Cardialysis is involved with the implementation and validation of these imaging techniques for use in cardiovascular clinical trials.

An example of this process is adoption of optical coherence tomography (OCT) by Cardialysis. OCT uses near-infrared light to provide micrometre-resolution, three-dimensional images. Through close links to the Thorax Center of Erasmus MC in Rotterdam, The Netherlands, Cardialysis became one of the first CROs to implement OCT.

Sticares InterACT is the contract research division of the Sticares Cardiovascular Research Institute and benefits from this link to the academic environment.

Benefits of partnering

Forming the strategic collaboration brings together complementary service offerings to extend the support both CROs can provide to clients.

For example, Cardialysis has medical monitoring capabilities in a number of European countries. However, large trials can need pan-European or global monitoring and consequently Cardialysis, and its clients, will benefit from capabilities Sticares InterACT has in this area.

Likewise, collaborating will enhance the core laboratory and statistic services Sticares InterACT can source for clients. Cardialysis also has expertise in web-based clinical event adjudication and data management.

The synergy resulting from this collaboration offers sponsors concrete and exceptional advantages​”, Karen Keukelaar, chief operating officer of Sticares InterACT, said in a press statement.

Related news

Show more

Related products

show more

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Elligo Health Research® | 23-Mar-2023 | Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

How Sponsors Reduce Chaos in Decentralized Trials

How Sponsors Reduce Chaos in Decentralized Trials

Florence Healthcare | 08-Mar-2023 | Insight Guide

89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...

Related suppliers

Follow us


View more